ANDA 71771, held by Warner Chilcott. Hydrochlorothiazide; Propranolol Hydrochloride.
As of Nov 22, 2026, ANDA 71771 (Propranolol Hydrochloride and Hydrochlorothiazide), held by Warner Chilcott, was first approved by FDA on Jan 26, 1988, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 26, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Propranolol Hydrochloride and Hydrochlorothiazide25MG;40MG · tablet;oral | Hydrochlorothiazide; Propranolol Hydrochloride | Discontinued |
| Jul 10, 1992 | Supplement 8Labeling | Approved | None posted |
| Jan 26, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters